Effect of low body weight on duration of the action of non-depolarizing muscle relaxant

Effect of low body weight on duration of the action of non-depolarizing muscle relaxant - duration of the action of rocuronium and low body weight

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015407

Enrollment

Registered

2016-03-31

Start date

2014-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients aged 18-75 years with ASA physical status 1 or 2 who are planned to undergo elective ophtalmologic or oto-rhino-laryngologic surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with normal liver and renal function who are planned to undergo elective ophtalmonogic or oto-rhino-laryngologic surgery

Exclusion criteria

Exclusion criteria: patients with neuromuscular disease or taking medications known to affect muscle relaxants or suffering from uncontrolled diabetes mellitus

Design outcomes

Primary

Measure	Time frame
comparison of duration of the action of rocuronium with an initial dose (0.6 mg/kg) and an additional dose (0.15 mg/kg) between patients with normal body weight (BMI 22-25) and low body weight (BMI <=18.5)	—

Countries

Japan

Contacts

Public ContactOsamu Takahata

Asahikawa Medical University Department of Anesthesiology and Critical Care Medicine

osamu@asahikawa-med.ac.jp81-166-68-2583

Outcome results